Clinical Diagnostics Technology & Disease Research News | 360Dx
Using Biomarkers in Breath, Zeteo Tech Aims to Find Respiratory Infections Sooner. The Maryland-based firm reported in a recent proof-of-concept study that It used protease biomarkers to identify patients with lower respiratory tract infections.
About Us - 360Dx
360Dx is published by GenomeWeb, an independent online news organization based in New York. Since 1997, GenomeWeb has served the global community of scientists, technology professionals, and executives who use and develop the latest advanced tools in molecular biology research and diagnostics. GenomeWeb is a family brand of Crain Communications.
Diagnostic Technologies and Applications - 360Dx
Texas Hospital CEO to Pay $5.3M to Settle Allegations of Kickbacks for Testing. Jeffrey Madison had been accused of participation in a scheme to pay kickbacks to physicians for testing referrals and billing healthcare programs for the tests. Oct 3, 2024.
UBS Initiates Coverage of Veracyte With Buy Rating | 360Dx
1 day ago · NEW YORK – Investment bank UBS on Tuesday initiated coverage of molecular diagnostics firm Veracyte with a Buy rating and a 12-month price target of $43 on the company's stock. In a note to investors, UBS analysts led by Lu Li noted that the bank envisions "durable growth" in Veracyte's core products, chiefly its Afirma thyroid nodule and ...
Genomics Research & Discovery - 360Dx
Jun 27, 2024 · MARAbio Systems Closes $19M Funding Round to Support Autism Test Commercialization. The company has developed a blood-based test to assess whether women are carriers of the antibodies that cause maternal autoantibody related-autism. The company is targeting its RPPA-based testing to biopharma firms as well as for clinical trial work and to ...
Breaking News - 360Dx
Oct 7, 2024 · Foundation Medicine Test Approved by FDA as CDx for Itovebi in Breast Cancer Patients. The test is approved for patients with endocrine-resistant, PIK3CA-mutated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer. Oct 11, 2024.
Top Five Articles on 360Dx Last Week: Roche, BARDA TBI …
3 days ago · NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: 1) Roche, BARDA Partner to Develop Diagnostics for Traumatic Brain Injuries 2) Lumos Diagnostics Sets Stage for US Expansion With New Contracts, Financing 3) Roche Leveraging New PCR Technology for 12-Target Respiratory Test 4) Cytovale Raises $100M in Series D Round
Genomics Technology, Tools & Methods | 360Dx
Oct 8, 2024 · The latest news on life science tools and technology in genetics, genomics, and molecular diagnostics from 360Dx.
Stratipath Seeks to Ramp up Adoption of AI-Based Breast Cancer …
6 days ago · NEW YORK – Digital pathology diagnostics firm Stratipath continues to establish itself in the clinic with its breast cancer prognostic test with recent data demonstrating strong performance in a cohort of more than 2000 breast cancer cases. The Swedish firm, founded in 2019 as a spinout from the Karolinska Institute, received a CE mark for ...
AmoyDx, AstraZeneca Partner on HER2 Lung Cancer CDx …
Aug 15, 2023 · Save for later. NEW YORK – Amoy Diagnostics said Tuesday that it has forged a partnership with AstraZeneca to develop its AmoyDx Essential NGS panel as a companion diagnostic for use in China with the drug firm's Enhertu (trastuzumab deruxtecan) antibody-drug conjugate for treatment of non-small cell lung cancer. Enhertu was jointly developed ...